Categories AlphaGraphs, Earnings, Retail

Ascena Retail Group (Nasdaq: ASNA) Q1 2019 Earnings Preview

Ascena Retail Group (ASNA), which owns brands such as Dressbarn, Maurices and Justice, is scheduled to post its first-quarter 2019 earnings after the market closes on Dec. 10, Monday.

The Street expects earnings of $0.03 per share for the quarter on revenue of $1.55 billion.

In the previous quarter, Ascena earned $0.07 per share, beating analyst projections. On the road to recovery from previous losses, the company has been earnings estimates twice in the last four quarters.

Specialty retailer and competitor Urban Outfitters (URBN) posted upbeat earnings less than a month ago, helped by comparable sales growth. Retail and wholesale sales grew 9% and 12%.

This new trend of recovery in specialty retail might extend itself to Ascena.

However, the company has already given its own outlook for the first quarter while it posted results of the previous one.

The owner of the Ann Taylor and Lane Bryant brands set the lower end of the guidance range at a $0.04-per share loss and the higher end at earnings of $0.06 per share for the first quarter. Net sales were forecast between $1.54 billion and $1.56 billion while comparable store sales was estimated to be between flat and up 2%.

For the whole of 2019, Ascena expects adjusted earnings of flat to $0.10 per share. Net sales were forecast to be in the range of $6.45 billion to $6.55 billion in 2019 when comparable sales are seen growing in low single digits.

“We entered Fiscal 2019 with good base momentum, and key growth initiatives beginning to gain traction across our brands. We are making headway with stabilization of our Dressbarn brand, and will continue to explore opportunities across our brand portfolio to create shareholder value,” CEO David Jaffe had stated back in September.

 

Follow our Google News edition to get the latest stock market, earnings, and financial news at your fingertips

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top